Connectivity of Pathology: The Olfactory System as a Model for Network-Driven Mechanisms of Alzheimer's Disease Pathogenesis
- PMID: 26696886
- PMCID: PMC4678206
- DOI: 10.3389/fnagi.2015.00234
Connectivity of Pathology: The Olfactory System as a Model for Network-Driven Mechanisms of Alzheimer's Disease Pathogenesis
Abstract
The pathogenesis of Alzheimer's disease (AD) has been postulated to preferentially impact specific neural networks in the brain. The olfactory system is a well-defined network that has been implicated in early stages of the disease, marked by impairment in olfaction and the presence of pathological hallmarks of the disease, even before clinical presentation. Discovering the cellular mechanisms involved in the connectivity of pathology will provide insight into potential targets for treatment. We review evidence from animal studies on sensory alteration through denervation or enrichment, which supports the notion of using the olfactory system to investigate the implications of connectivity and activity in the spread of pathology in AD.
Keywords: Alzheimer’s disease; amyloid beta; connectivity; denervation; enrichment; olfaction.
Figures
Similar articles
-
Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageing.Brain. 2018 May 1;141(5):1486-1500. doi: 10.1093/brain/awy053. Brain. 2018. PMID: 29522171 Free PMC article.
-
Functional Connectivity between the Resting-State Olfactory Network and the Hippocampus in Alzheimer's Disease.Brain Sci. 2019 Nov 25;9(12):338. doi: 10.3390/brainsci9120338. Brain Sci. 2019. PMID: 31775369 Free PMC article.
-
An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.J Proteomics. 2016 Oct 4;148:149-58. doi: 10.1016/j.jprot.2016.07.032. Epub 2016 Aug 3. J Proteomics. 2016. PMID: 27498392
-
Alzheimer's Disease: What Can We Learn From the Peripheral Olfactory System?Front Neurosci. 2020 May 19;14:440. doi: 10.3389/fnins.2020.00440. eCollection 2020. Front Neurosci. 2020. PMID: 32508565 Free PMC article. Review.
-
Alzheimer's disease.Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Subcell Biochem. 2012. PMID: 23225010 Review.
Cited by
-
Association of Odor Identification Ability With Amyloid-β and Tau Burden: A Systematic Review and Meta-Analysis.Front Neurosci. 2020 Nov 26;14:586330. doi: 10.3389/fnins.2020.586330. eCollection 2020. Front Neurosci. 2020. PMID: 33324151 Free PMC article.
-
Nasal Aβ42 mirrors brain amyloid dynamics and cognitive decline across the Alzheimer's disease continuum.Sci Rep. 2025 Aug 19;15(1):30413. doi: 10.1038/s41598-025-15230-2. Sci Rep. 2025. PMID: 40830651 Free PMC article.
-
RGS2 expression predicts amyloid-β sensitivity, MCI and Alzheimer's disease: genome-wide transcriptomic profiling and bioinformatics data mining.Transl Psychiatry. 2016 Oct 4;6(10):e909. doi: 10.1038/tp.2016.179. Transl Psychiatry. 2016. PMID: 27701409 Free PMC article.
-
Alteration of Neural Pathways and Its Implications in Alzheimer's Disease.Biomedicines. 2022 Apr 4;10(4):845. doi: 10.3390/biomedicines10040845. Biomedicines. 2022. PMID: 35453595 Free PMC article. Review.
-
Endocannabinoid-mediated neuromodulation in the main olfactory bulb at the interface of environmental stimuli and central neural processing.Eur J Neurosci. 2022 Feb;55(4):1002-1014. doi: 10.1111/ejn.15186. Epub 2021 Apr 2. Eur J Neurosci. 2022. PMID: 33724578 Free PMC article. Review.
References
-
- Attems J., Jellinger K. A. (2006). Olfactory tau pathology in Alzheimer disease and mild cognitive impairment. Clin. Neuropathol. 25, 265–271. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources